H. I. Seifart - Concepedia

Author

H. I. Seifart

Also Known As

H I Seifart, H SEIFART, H. I. Seifart, H.I. Seifart, HEINER SEIFART, HEINER I. SEIFART, HI Seifart, Heiner I Seifart, Heiner I. Seifart, Heiner Seifart

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Stellenbosch University Tygerberg Hospital Desmond Tutu HIV Foundation Charité - Universitätsmedizin Berlin London School of Hygiene & Tropical Medicine

About

H. I. Seifart is an author at Stellenbosch University specializing in medicine, pharmacology, and tuberculosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	885
2	Biochemistry	3	3	138
3	Health Sciences	2	2	144
4	Public Health	1	1	15
5	Allergy	1	1	191

H. I. Seifart

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis. D. P. Parkin, Sam Vandenplas, F J Botha, American Journal of Respiratory and Critical Care Medicine Pulmonary TuberculosisAllergyTuberculosis PreventionPharmacologyEliminator Subgroups	1997	191
The Early Bactericidal Activity of Isoniazid Related to Its Dose Size in Pulmonary Tuberculosis PETER R. DONALD, FREDERICK A. SIRGEL, FREDERICK J. BOTHA, American Journal of Respiratory and Critical Care Medicine Tuberculosis PreventionBactericidal ActivityAntimicrobial ChemotherapyDrug ResistanceMedical Microbiology	1997	124
Pharmacokinetics of Isoniazid, Rifampin, and Pyrazinamide in Children Younger than Two Years of Age with Tuberculosis: Evidence for Implementation of Revised World Health Organization Recommendations Stephanie Thee, James A. Seddon, Peter R. Donald, Antimicrobial Agents and Chemotherapy	2011	110
The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid Peter R. Donald, D. P. Parkin, H. I. Seifart, European Journal of Clinical Pharmacology Pharmacological StudyMedicinePhysiologyPharmacotherapyPharmacology	2007	98
High-performance liquid chromatographic determination of isoniazid, acetylisoniazid and hydrazine in biological fluids H. I. Seifart, W. L. G. Gent, D. P. Parkin, Journal of Chromatography B Biomedical Sciences and Applications Biological FluidsChemical MeasurementBiochemistryGas ChromatographyMedicine	1995	98
The Influence of Human N-Acetyltransferase Genotype on the Early Bactericidal Activity of Isoniazid Peter R. Donald, F A Sirgel, Amour Venter, Clinical Infectious Diseases	2004	89
Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis PETER R. DONALD, H. I. Seifart The Journal of Pediatrics Cerebrospinal FluidTuberculosisTuberculous MeningitisBacterial MeningitisMedicine	1989	69
Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended doses Simbarashe Zvada, Paolo Denti, P. R. Donald, Journal of Antimicrobial Chemotherapy	2014	60
Cerebrospinal Fluid Isoniazid Concentrations in Children With Tuberculous Meningitis: The Influence of Dosage and Acetylation Status PETER R. DONALD, W. L. G. Gent, H. I. Seifart, PEDIATRICS	1992	42
The pharmacokinetics of enteral antituberculosis drugs in patients requiring intensive care Coenraad F.N. Koegelenberg, André Nortje, Usha Lalla, South African Medical Journal	2013	40

Page 1